{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:23:14Z","timestamp":1786980194027,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07130-y","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:31:12Z","timestamp":1780464672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early effect of CFTR modulators on the mental health of patients with cystic fibrosis and parents"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1316-9545","authenticated-orcid":false,"given":"Hande","family":"Yeti\u015fgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eule Selin","family":"Akyan Soyda\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sat\u0131","family":"\u00d6zkan Tabak\u00e7\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u015f\u0131l","family":"Bilgi\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"K\u00fcrt\u00fcl \u00c7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Akca Din\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayy\u00fcce","family":"\u00dcnl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7elebi","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet Ali","family":"\u00c7etin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6k\u00e7en Dil\u015fa","family":"Tu\u011fcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilber","family":"Ademhan Tural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanem","family":"Ery\u0131lmaz Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclser","family":"\u015eenses Din\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"\u00c7\u00f6p","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fczin","family":"Cinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"9","key":"7130_CR1","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s00431-021-04168-y","volume":"180","author":"MC Bierlaagh","year":"2021","unstructured":"Bierlaagh MC, Muilwijk D, Beekman JM, van der Ent CK (2021) A new era for people with cystic fibrosis. Eur J Pediatr 180(9):2731\u20132739. https:\/\/doi.org\/10.1007\/s00431-021-04168-y","journal-title":"Eur J Pediatr"},{"issue":"10","key":"7130_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.5694\/mja2.52119","volume":"219","author":"S Kumar","year":"2023","unstructured":"Kumar S, Soldatos G, Teede HJ, Pallin M (2023) Effects of modulator therapies on endocrine complications in adults with cystic fibrosis: a narrative review. Med J Aust 219(10):496\u2013502. https:\/\/doi.org\/10.5694\/mja2.52119","journal-title":"Med J Aust"},{"issue":"9","key":"7130_CR3","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/ppul.26535","volume":"58","author":"S Uytun","year":"2023","unstructured":"Uytun S, Cinel G, Ery\u0131lmaz Polat S, \u00d6zkan Tabak\u00e7\u0131 S, Kiper N, Yal\u00e7\u0131n E et al (2023) Patients with cystic fibrosis who could not receive the CFTR modulator treatment: what did they lose in 1 year? Pediatr Pulmonol 58(9):2505\u20132512. https:\/\/doi.org\/10.1002\/ppul.26535","journal-title":"Pediatr Pulmonol"},{"key":"7130_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-2600(24)00411-9","volume":"13","author":"C Keating","year":"2025","unstructured":"Keating C, Yonker LM, Vermeulen F et al (2025) Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials. Lancet Respir Med 13:256\u2013271","journal-title":"Lancet Respir Med"},{"key":"7130_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/17476348.2021.1855980","volume":"15","author":"PG Middleton","year":"2021","unstructured":"Middleton PG, Taylor-Cousar JL (2021) Development of elexacaftor\u2013tezacaftor\u2013ivacaftor: highly effective CFTR modulation for the majority of people with cystic fibrosis. Expert Rev Respir Med 15:723\u2013735","journal-title":"Expert Rev Respir Med"},{"issue":"7","key":"7130_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.1172","volume":"11","author":"PG Middleton","year":"2023","unstructured":"Middleton PG, Simmonds NJ (2023) Cystic fibrosis modulator therapy can reverse cystic bronchiectasis. Respirol Case Rep 11(7):e01172. https:\/\/doi.org\/10.1002\/rcr2.1172","journal-title":"Respirol Case Rep"},{"issue":"6","key":"7130_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/MCP.0000000000001014","volume":"29","author":"MB VanElzakker","year":"2023","unstructured":"VanElzakker MB, Tillman EM, Yonker LM, Ratai EM, Georgiopoulos AM (2023) Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort. Curr Opin Pulm Med 29(6):603\u2013609. https:\/\/doi.org\/10.1097\/MCP.0000000000001014","journal-title":"Curr Opin Pulm Med"},{"issue":"7","key":"7130_CR8","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/ppul.26412","volume":"58","author":"E Baroud","year":"2023","unstructured":"Baroud E, Chaudhary N, Georgiopoulos AM (2023) Management of neuropsychiatric symptoms in adults treated with elexacaftor\/tezacaftor\/ivacaftor. Pediatr Pulmonol 58(7):1920\u20131930. https:\/\/doi.org\/10.1002\/ppul.26412","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"7130_CR9","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/ppul.27100","volume":"59","author":"H Pham","year":"2024","unstructured":"Pham H, Vandeleur M, Mainzer RM, Ranganathan S (2024) Mental health, sleep, and respiratory health after initiating ETI in children with CF. Pediatr Pulmonol 59(10):2606\u20132613. https:\/\/doi.org\/10.1002\/ppul.27100","journal-title":"Pediatr Pulmonol"},{"key":"7130_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/17534666221144211","volume":"16","author":"L Zhang","year":"2022","unstructured":"Zhang L, Albon D, Jones M, Bruschwein H (2022) Impact of ETI on depression and anxiety in cystic fibrosis. Ther Adv Respir Dis 16:17534666221144211. https:\/\/doi.org\/10.1177\/17534666221144211","journal-title":"Ther Adv Respir Dis"},{"issue":"6","key":"7130_CR11","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jcf.2022.05.001","volume":"21","author":"G Spoletini","year":"2022","unstructured":"Spoletini G, Gillgrass L, Pollard K, Shaw N, Williams E, Etherington C et al (2022) Dose adjustments of elexacaftor\/tezacaftor\/ivacaftor in response to mental health side effects in adults with cystic fibrosis. J Cyst Fibros 21(6):1061\u20131065. https:\/\/doi.org\/10.1016\/j.jcf.2022.05.001","journal-title":"J Cyst Fibros"},{"issue":"1","key":"7130_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5863\/1551-6776-29.1.82","volume":"29","author":"SR Duehlmeyer","year":"2024","unstructured":"Duehlmeyer SR, Elson EC, Oermann CM (2024) New tic disorder in a child treated with ETI. J Pediatr Pharmacol Ther 29(1):82\u201384. https:\/\/doi.org\/10.5863\/1551-6776-29.1.82","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"7130_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jcf.2023.01.015","volume":"22","author":"M Arslan","year":"2023","unstructured":"Arslan M, Chalmers S, Rentfrow K, Olson JM, Dean V, Wylam ME, Demirel N (2023) Suicide attempts in adolescents with cystic fibrosis on elexacaftor\/tezacaftor\/ivacaftor therapy. J Cyst Fibros 22(3):427\u2013430. https:\/\/doi.org\/10.1016\/j.jcf.2023.01.015","journal-title":"J Cyst Fibros"},{"issue":"3","key":"7130_CR14","doi-asserted-by":"publisher","first-page":"e71037","DOI":"10.1002\/ppul.71037","volume":"60","author":"B Uzunoglu","year":"2025","unstructured":"Uzunoglu B, Selcuk Balci M, Kalyoncu M et al (2025) ETI accessibility and mental health. Pediatr Pulmonol 60(3):e71037. https:\/\/doi.org\/10.1002\/ppul.71037","journal-title":"Pediatr Pulmonol"},{"key":"7130_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2024.07.008","author":"M Nguyen","year":"2024","unstructured":"Nguyen M, MacDiarmid P, Tanzler A et al (2024) Impact of ETI on anxiety and depression in adults with CF. J Cyst Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2024.07.008","journal-title":"J Cyst Fibros"},{"issue":"1","key":"7130_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-025-00879-0","volume":"9","author":"F Buniotto","year":"2025","unstructured":"Buniotto F, Tridello G, De Scolari A, Meneghelli I, Pintani E, Perobelli S, Cipolli M (2025) Improved quality of life in cystic fibrosis patients observed up to 36 months after starting elexacaftor\/tezacaftor\/ivacaftor treatment. J Patient Rep Outcomes 9(1):48. https:\/\/doi.org\/10.1186\/s41687-025-00879-0","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"7130_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.71461","volume":"61","author":"S K\u00fcmmerli","year":"2026","unstructured":"K\u00fcmmerli S, Elviro CF, Regamey N, Mornand A, Faouzi M, Rochat I, Blanchon S (2026) Impact of elexacaftor\u2013tezacaftor\u2013ivacaftor on quality of life in children with cystic fibrosis. Pediatr Pulmonol 61(1):e71461. https:\/\/doi.org\/10.1002\/ppul.71461","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl","key":"7130_CR18","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","volume":"181","author":"PM Farrell","year":"2017","unstructured":"Farrell PM, White TB, Ren CL et al (2017) Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. J Pediatr 181(Suppl):S4-S15.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.09.064","journal-title":"J Pediatr"},{"key":"7130_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/jpepsy\/jsg044","volume":"28","author":"AC Modi","year":"2003","unstructured":"Modi AC, Quittner AL (2003) Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 28:535\u2013546","journal-title":"J Pediatr Psychol"},{"issue":"2","key":"7130_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11136-012-0152-4","volume":"22","author":"H Yuksel","year":"2013","unstructured":"Yuksel H, Yilmaz O, Dogru D, Karadag B, Unal F, Quittner AL (2013) Reliability and validity of the Cystic Fibrosis Questionnaire-Revised for children and parents in Turkey. Qual Life Res 22(2):409\u2013414. https:\/\/doi.org\/10.1007\/s11136-012-0152-4","journal-title":"Qual Life Res"},{"issue":"4","key":"7130_CR21","first-page":"995","volume":"21","author":"M Kovacs","year":"1985","unstructured":"Kovacs M (1985) The Children\u2019s Depression Inventory (CDI). Psychopharmacol Bull 21(4):995\u2013998","journal-title":"Psychopharmacol Bull"},{"key":"7130_CR22","first-page":"132","volume":"2","author":"B \u00d6y","year":"1991","unstructured":"\u00d6y B (1991) Depression scale for children: validity and reliability study. Turk Psikiyatri Derg 2:132\u2013137","journal-title":"Turk Psikiyatri Derg"},{"issue":"10","key":"7130_CR23","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1097\/00004583-199910000-00011","volume":"38","author":"B Birmaher","year":"1999","unstructured":"Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M (1999) Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED). J Am Acad Child Adolesc Psychiatry 38(10):1230\u20131236. https:\/\/doi.org\/10.1097\/00004583-199910000-00011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"7130_CR24","unstructured":"Karaceylan \u00c7akmak\u00e7\u0131 F (2004) \u00c7ocuklarda Anksiyete Bozukluklar\u0131n\u0131 Tarama \u00d6l\u00e7e\u011fi: ge\u00e7erlik ve g\u00fcvenirlik \u00e7al\u0131\u015fmas\u0131. Uzmanl\u0131k tezi. Kocaeli \u00dcniversitesi T\u0131p Fak\u00fcltesi"},{"key":"7130_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561\u2013571. https:\/\/doi.org\/10.1001\/archpsyc.1961.01710120031004","journal-title":"Arch Gen Psychiatry"},{"issue":"23","key":"7130_CR26","first-page":"3","volume":"7","author":"N Hisli","year":"1989","unstructured":"Hisli N (1989) Beck Depresyon Envanterinin \u00fcniversite \u00f6\u011frencileri i\u00e7in ge\u00e7erli\u011fi ve g\u00fcvenirli\u011fi. Psikoloji Derg 7(23):3\u201313","journal-title":"Psikoloji Derg"},{"issue":"6","key":"7130_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56(6):893\u2013897. https:\/\/doi.org\/10.1037\/0022-006X.56.6.893","journal-title":"J Consult Clin Psychol"},{"key":"7130_CR28","first-page":"163","volume":"12","author":"M Ulusoy","year":"1998","unstructured":"Ulusoy M, \u015eahin N, Erkmen H (1998) Turkish version of the Beck Anxiety Inventory: psychometric properties. J Cogn Psychother 12:163\u2013172","journal-title":"J Cogn Psychother"},{"issue":"3","key":"7130_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"WHOQOL Group","year":"1998","unstructured":"WHOQOL Group (1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 28(3):551\u2013558. https:\/\/doi.org\/10.1017\/S0033291798006667","journal-title":"Psychol Med"},{"key":"7130_CR30","unstructured":"Eser SY, Fidaner H, Fidaner C et al (1999) Measure of quality of life WHOQOL-100 and WHOQOL-BREF. 3P Dergisi 7:5\u201313"},{"issue":"12","key":"7130_CR31","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","volume":"69","author":"AL Quittner","year":"2014","unstructured":"Quittner AL, Goldbeck L, Abbott J, Duff A, Lambrecht P, Sol\u00e9 A et al (2014) Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers. Thorax 69(12):1090\u20131097. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-205983","journal-title":"Thorax"},{"issue":"1","key":"7130_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.24953\/turkjped.2018.01.005","volume":"60","author":"G \u015eenses-Din\u00e7","year":"2018","unstructured":"\u015eenses-Din\u00e7 G, \u00d6z\u00e7elik U, \u00c7ak T, Do\u011fru-Ers\u00f6z D, \u00c7\u00f6p E, Yal\u00e7\u0131n E et al (2018) Psychiatric morbidity and quality of life in children and adolescents with cystic fibrosis. Turk J Pediatr 60(1):32\u201340. https:\/\/doi.org\/10.24953\/turkjped.2018.01.005","journal-title":"Turk J Pediatr"},{"key":"7130_CR33","doi-asserted-by":"publisher","first-page":"1531514","DOI":"10.3389\/fphar.2025.1531514","volume":"16","author":"C Zhu","year":"2025","unstructured":"Zhu C, Cui Z, Liu T et al (2025) Real-world safety profile of elexacaftor\/tezacaftor\/ivacaftor. Front Pharmacol 16:1531514. https:\/\/doi.org\/10.3389\/fphar.2025.1531514","journal-title":"Front Pharmacol"},{"issue":"1","key":"7130_CR34","doi-asserted-by":"publisher","first-page":"e27393","DOI":"10.1002\/ppul.27393","volume":"60","author":"K Pasley","year":"2025","unstructured":"Pasley K, Eisner M, Sliemers S et al (2025) Mental health of pediatric patients with CF after 18 months on ETI. Pediatr Pulmonol 60(1):e27393. https:\/\/doi.org\/10.1002\/ppul.27393","journal-title":"Pediatr Pulmonol"},{"key":"7130_CR35","doi-asserted-by":"publisher","first-page":"1179208","DOI":"10.3389\/fphar.2023.1179208","volume":"14","author":"L Piehler","year":"2023","unstructured":"Piehler L, Thalemann R, Lehmann C et al (2023) Effects of ETI on mental health in CF. Front Pharmacol 14:1179208. https:\/\/doi.org\/10.3389\/fphar.2023.1179208","journal-title":"Front Pharmacol"},{"issue":"9","key":"7130_CR36","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1164\/rccm.202308-1317OC","volume":"208","author":"P McNally","year":"2023","unstructured":"McNally P, Lester K, Stone G et al (2023) RECOVER Trial: ETI improves lung clearance index and CT scores. Am J Respir Crit Care Med 208(9):917\u2013929. https:\/\/doi.org\/10.1164\/rccm.202308-1317OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7130_CR37","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202501-103OC","author":"JE Pittman","year":"2025","unstructured":"Pittman JE, Morgan S, McCreary M et al (2025) Clinical effectiveness of ETI in children aged 6\u201311 years. Ann Am Thorac Soc. https:\/\/doi.org\/10.1513\/AnnalsATS.202501-103OC","journal-title":"Ann Am Thorac Soc"},{"key":"7130_CR38","first-page":"1","volume":"15","author":"G Din\u00e7","year":"2017","unstructured":"Din\u00e7 G et al (2017) Kistik fibrozisli \u00e7ocuklar\u0131n annelerinde psikiyatrik belirti ve ba\u015f etme becerileri. T\u00fcrkiye \u00c7ocuk Hastal\u0131klar\u0131 Dergisi 15:1\u20138","journal-title":"T\u00fcrkiye \u00c7ocuk Hastal\u0131klar\u0131 Dergisi"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07130-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:26:09Z","timestamp":1784283969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07130-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["7130"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07130-y","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ankara Bilkent City Hospital local ethics committee (TABED 2\u201324-420) and conducted following the Declaration of Helsinki.\u00a0","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each patient and their parents before starting the modulators.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"464"}}